viernes, 21 de julio de 2023

FDA approves quizartinib for newly diagnosed acute myeloid leukemia

https://www.fda.gov/drugs/drug-approvals-and-databases/fda-approves-quizartinib-newly-diagnosed-acute-myeloid-leukemia

No hay comentarios:

Publicar un comentario